YATHARTH · Yatharth Hospital & Trauma Care Services Ltd · Healthcare Facilities
YATHARTH · Yatharth Hospital & Trauma Care Services Ltd · Healthcare Facilities
As of 06 Nov close
52-week range
13.6% below 52-week high
52-week range: as of 06 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 16 Oct 2026
Revenue (latest Q)
₹393 Cr
Revenue YoY
PAT YoY
+11.9%
Operating margin
Revenue, last 5 quarters
Source: Yahoo Finance, as of 30 Jun 2026
P/E (TTM)
P/B
5
P/S (TTM)
Not available from data source
Sector P/E
Not available from data source
Dividend yield
+0.1%
Source: Yahoo Finance, as of 29 Oct 2026
No peer comparison data on file for YATHARTH.
Promoter
stable
FII
rising 1q
MF
9.74% (+0.37pp)
rising 3q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| canonicalSymbol | date | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| YATHARTH | 2026-07-14 | 500000 | 1 | WEAK | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: During the earnings call for Q1 FY27, management reported a record quarterly revenue of INR 3,927 million, reflecting a 51% year-on-year growth, and an EBITDA of INR 917 million. The company achieved a significant milestone with its Faridabad Sector 20 hospital reaching EBITDA breakeven in just 9 months. The new hospitals in Greater Faridabad, New Delhi, and Agra contributed 27% to total revenue. Management highlighted a strong focus on improving the payer mix, with new hospitals operating at over 90% cash and private insurance patients. The company also announced a maiden interim dividend of 5% and introduced an ESOP scheme to attract and retain talent. Management set a goal to double bed capacity to 5,000 beds within the next few years, with ongoing expansions and new acquisitions planned. The overall adjusted EBITDA margin stood at 28.1%, excluding the impact of new facilities, indicating improved profitability across the network.
Management emphasized strong growth and successful operational milestones.
Sourced from an exchange-filed transcript, dated 18 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Yatharth Hospital & Trauma Care Services Limited for Q1 FY27 reported a revenue of Rs 3,927 million, reflecting a 51% year-over-year increase and a 15% quarter-over-quarter increase. EBITDA was reported at Rs 917 million, up 39% year-over-year and 15% quarter-over-quarter, with an EBITDA margin of 23.3%. The adjusted EBITDA margin, excluding ramp-up losses from new hospitals, was noted at 28.1%. The presentation highlighted that new hospitals contributed 27% to the revenue mix, and the company achieved EBITDA breakeven for the Faridabad Sector-20 hospital within nine months. Management also announced a first interim dividend of 5% of face value and discussed ongoing ESG initiatives. The document emphasized the company's growth strategy, including plans for capacity expansion and enhancing the specialty mix across its network.
The presentation highlighted strong financial growth and strategic initiatives.
Sourced from an exchange-filed presentation, dated 11 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Yatharth Hospital & Trauma Care Services Limited for Q1 FY27 reported a revenue of Rs 3,927 million, reflecting a 51% year-over-year increase and a 15% quarter-over-quarter increase. EBITDA was reported at Rs 917 million, up 39% YoY and 15% QoQ, with an EBITDA margin of 23.3%. The adjusted EBITDA margin, excluding ramp-up losses from new hospitals, was 28.1%. The presentation highlighted that new hospitals contributed 27% to the revenue mix, and the company achieved EBITDA breakeven for the Faridabad Sector-20 hospital within nine months. Management announced a first interim dividend of 5% of face value and detailed ongoing ESG initiatives. The company aims to expand its bed capacity to over 5,000 beds in the next three years, with a focus on enhancing its specialty services and improving payer mix.
Management emphasized strong revenue and EBITDA growth along with strategic expansion plans.
Sourced from an exchange-filed presentation, dated 10 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the earnings conference call for Q4 FY26, management reported that FY26 was a transformative year for Yatharth Hospital & Trauma Care Services Limited, characterized by strong operational execution and strategic expansion. The company achieved consolidated revenue of approximately INR 12,072 million, reflecting a 36% year-over-year growth, while EBITDA increased by 30% to INR 2,921 million. Management highlighted significant clinical milestones and investments in advanced medical technologies. The company announced plans for a new super-speciality hospital in Gurugram, with an investment of around INR 200 crores. Newly operational hospitals in New Delhi and Faridabad contributed approximately 11% to revenue in Q4 FY26. Management also discussed their focus on international collaborations and the aim to reach a total bed capacity of 5,000 beds within three years. The call concluded with management expressing confidence in sustaining growth momentum and operational efficiencies moving forward.
Management emphasized strong growth and operational achievements throughout the year.
Sourced from an exchange-filed transcript, dated 04 Jun 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Yatharth Hospital & Trauma Care Services Limited detailed the financial results for Q4 and FY26, highlighting significant growth across various metrics. Revenue for Q4 FY26 reached Rs 3,416 million, a 47% increase year-over-year, while EBITDA rose by 37% to Rs 799 million. The presentation noted a robust EBITDA margin of 23.4%, with an adjusted margin of 30.4% after accounting for ramp-up losses from new hospitals. For FY26, total revenue was reported at Rs 12,072 million, reflecting a 36% increase, and PAT grew by 30% to Rs 1,703 million. The company also emphasized its strategic expansion plans, including the acquisition of a 250-bedded hospital in Gurugram and the ramp-up of new facilities in New Delhi and Faridabad. Management reported a cash conversion ratio of 98%, significantly improved from the previous year. The presentation concluded with a focus on enhancing governance and operational efficiency.
Management emphasized strong financial performance and strategic growth initiatives.
Sourced from an exchange-filed presentation, dated 25 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: During the earnings conference call for Q3 FY26, management reported a robust 46% year-over-year revenue growth, achieving the highest quarterly revenue and profitability in the company's history. The newly operational hospitals in New Delhi and Faridabad Sector-20 contributed INR279 million in revenue, accounting for 9% of the group's total revenue. Management highlighted the successful integration of the Agra hospital into the network and emphasized the focus on clinical excellence, showcasing advanced medical interventions performed during the quarter. The company achieved an EBITDA of INR742 million, reflecting a 35% year-over-year increase. Management noted a healthy occupancy rate of 67% across the network and expressed confidence in sustaining growth momentum while enhancing operational efficiencies. The discussion also covered plans for future expansions, aiming for a total of 5,000 beds over the next three years, with a capex of INR1,500 crores. Overall, the call conveyed a strong performance and strategic direction for the company.
Management emphasized strong growth and operational achievements during the quarter.
Sourced from an exchange-filed transcript, dated 13 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Yatharth Hospital & Trauma Care Services Limited for Q3 FY26 reported significant financial growth, with revenue increasing by 46% year-over-year to Rs. 3,205 million. The EBITDA also rose by 35% to Rs. 742 million, resulting in an EBITDA margin of 23.2%. The presentation highlighted the successful integration of the Agra hospital and the ramp-up of new facilities in New Delhi and Faridabad, which contributed to 9% of group revenues within their first quarter of operations. Management noted a strong average revenue per occupied bed (ARPOB) of Rs. 33,744, reflecting a 10% increase year-over-year. The company emphasized its strategic acquisitions and expansions, positioning itself as a leading healthcare provider in North India. Additionally, the presentation outlined plans for enhancing clinical infrastructure and diversifying revenue streams across hospitals.
Management emphasized strong financial performance and strategic growth initiatives.
Sourced from an exchange-filed presentation, dated 05 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedYatharth Hospital & Trauma Care Services Limited's annual report outlines its strategic focus on expanding specialized healthcare services beyond geographic boundaries, enhancing clinical excellence, and investing in talent development. The report highlights the company's commitment to integrated healthcare delivery, operational efficiency, and quality management. It also emphasizes the importance of corporate governance, sustainability initiatives, and stakeholder engagement.
- Expansion of specialized healthcare services beyond geographic boundaries to increase accessibility.
- Commitment to clinical excellence through advanced technology and continuous training programs.
- Focus on talent development through partnerships with medical institutions and residency programs.
- Emphasis on corporate governance, sustainability, and stakeholder engagement.
- Integrated healthcare model with a focus on operational efficiency and quality management.
Key takeaway: Yatharth Hospitals is focused on expanding its specialized healthcare services beyond geographic boundaries while maintaining clinical excellence and investing in talent development.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Auditor Qualification (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Auditor Qualification
1 occurrenceEarlier (1-3 years ago)
The internal auditor resigned on 3rd February 2024, and the appointment of a new internal auditor is pending.
Routine disclosures
Contingent Liability
3 occurrencesRecent (last 12 months)
The company has a contingent liability related to EPCG obligations, with a remaining balance of INR 206.26 million to be fulfilled.
Earlier (1-3 years ago)
The company has provided corporate guarantees for loans to its subsidiary, and the income tax department has provisionally attached shares held by the company and its group, under Section 281B of the IT Act.
The Income Tax Department seized ₹5.21 million in cash from the company and imposed a lien of ₹528.60 million on its current accounts due to a search action initiated on 19th October 2023. The company has not made any provision for these contingent liabilities.
Related-Party Transaction
3 occurrencesRecent (last 12 months)
The company provided loans to related parties, including Yatharth Super Speciality Hospital and subsidiaries, with amounts and details disclosed in the financial statements for the year ended March 31, 2026.
Earlier (1-3 years ago)
The company has made sales of medicines to related parties including AKS Medical & Research Private Limited, Ramraja Multispeciality Hospital & Trauma Centre Private Limited, and Pristine Infracon Private Limited during the year ended 31 March 2025.
The company has disclosed related party transactions involving key managerial personnel and their affiliated entities, including Yatharth Hospital & Trauma Care Services Limited and AKS Medical & Research Private Limited.
Promoter Share Pledge
1 occurrenceRecent (last 12 months)
11.9% of promoter holding pledged (quarter 2026-Q3 as of 2026-07-18).